Skip to main content

Advertisement

Log in

Methylphenidate disrupts cytoskeletal homeostasis and reduces membrane-associated lipid content in juvenile rat hippocampus

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

A Correction to this article was published on 15 December 2022

This article has been updated

Abstract

Although methylphenidate (MPH) is ubiquitously prescribed to children and adolescents, the consequences of chronic utilization of this psychostimulant are poorly understood. In this study, we investigated the effects of MPH on cytoskeletal homeostasis and lipid content in rat hippocampus. Wistar rats received intraperitoneal injections of MPH (2.0 mg/kg) or saline solution (controls), once a day, from the 15th to the 44th day of age. Results showed that MPH provoked hypophosphorylation of glial fibrillary acidic protein (GFAP) and reduced its immunocontent. Middle and high molecular weight neurofilament subunits (NF-M, NF-H) were hypophosphorylated by MPH on KSP repeat tail domains, while NFL, NFM and NFH immunocontents were not altered. MPH increased protein phosphatase 1 (PP1) and 2A (PP2A) immunocontents. MPH also decreased the total content of ganglioside and phospholipid, as well as the main brain gangliosides (GM1, GD1a, and GD1b) and the major brain phospholipids (sphingomyelin, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, and phosphatidylserine). Total cholesterol content was also reduced in the hippocampi of juvenile rats treated with MPH. These results provide evidence that disruptions of cytoskeletal and lipid homeostasis in hippocampus of juvenile rats are triggers by chronic MPH treatment and present a new basis for understanding the effects and consequences associated with chronic use of this psychostimulant during the development of the central nervous system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Change history

Abbreviations

ADHD:

Attention deficit hyperactivity disorder

CNS:

Central nervous system

GFAP:

Glial fibrillary acidic protein

IFs:

Intermediate filaments

KSP:

Lysine-serine-proline

MPH:

Methylphenidate

NF:

Neurofilament

NFH:

High molecular weight neurofilament subunit

NFL:

Light molecular weight neurofilament subunit

NFM:

Middle molecular weight neurofilament subunit

PP1:

Protein phosphatase 1

PP2A:

Protein phosphatase 2A

PP2B:

Calcineurin

References

Download references

Acknowledgements

This work was supported in part by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq–Brazil).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angela T. S. Wyse.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest with the contents of this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schmitz, F., Pierozan, P., Biasibetti-Brendler, H. et al. Methylphenidate disrupts cytoskeletal homeostasis and reduces membrane-associated lipid content in juvenile rat hippocampus. Metab Brain Dis 33, 693–704 (2018). https://doi.org/10.1007/s11011-017-0177-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-017-0177-z

Keywords

Navigation